Artivion (AORT) Asset Writedowns and Impairment (2010 - 2024)
Artivion (AORT) posted Asset Writedowns and Impairment of $3.9 million for Q4 2024, up 506.41% on a QoQ basis from $640000.0 in Q3 2024, and up 501.34% year-over-year from $645387.3 in Q1 2024.
Artivion (AORT) Asset Writedowns and Impairment (2010 - 2024) Analysis & Trends
Artivion's Asset Writedowns and Impairment history runs 7 years deep, the most recent figure standing at $3.9 million for Q4 2024.
- Quarterly Asset Writedowns and Impairment rose 501.34% year-over-year to $3.9 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $5.7 million (up 319.66% YoY) and the FY2024 annual result came in at $5.7 million, up 319.66% from the prior year.
- Asset Writedowns and Impairment was $3.9 million for Q4 2024 at Artivion, up from $640000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $4.9 million in Q4 2021 and bottomed at -$1.5 million in Q3 2021.
- A 4-year average of $931437.5 and a median of $642000.0 in 2024 frame the typical range for Asset Writedowns and Impairment.
- Annual changes were most pronounced in 2023 — Asset Writedowns and Impairment sank 229.8% — and 2024, when it surged 501.34%.
- Artivion's Asset Writedowns and Impairment stood at $4.9 million in 2021, then plunged by 84.8% to $745000.0 in 2022, then sank by 229.8% to -$967000.0 in 2023, then jumped by 501.34% to $3.9 million in 2024.
- Business Quant data shows AORT's Asset Writedowns and Impairment at $3.9 million in Q4 2024, $640000.0 in Q3 2024, and $534000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Artivion | 1.26 Bn | 1.20 Bn | 75.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 3.88 Mn |
| Dec 31, 2024 | 3.88 Mn |
| Sep 30, 2024 | 640,000.00 |
| Sep 30, 2024 | 640,000.00 |
| Jun 30, 2024 | 534,000.00 |
| Jun 30, 2024 | 534,000.00 |
| Mar 31, 2024 | 644,000.00 |
| Mar 31, 2024 | 644,000.00 |
| Dec 31, 2023 | -967,000.00 |
| Dec 31, 2023 | -967,000.00 |
| Sep 30, 2023 | 489,000.00 |
| Sep 30, 2023 | 489,000.00 |
| Jun 30, 2023 | 1.08 Mn |
| Jun 30, 2023 | 1.08 Mn |
| Mar 31, 2023 | 754,000.00 |
| Mar 31, 2023 | 754,000.00 |
| Dec 31, 2022 | 745,000.00 |
| Dec 31, 2022 | 745,000.00 |
| Sep 30, 2022 | 583,000.00 |
| Sep 30, 2022 | 583,000.00 |